Exxon Mobil Boosts Q2 Performance While Acquiring Superior Graphite and Strengthening Dividend
On August 1, 2025, Exxon Mobil Corporation (NYSE:XOM) reported Q2 2025 earnings of $7.1 billion.
Insider Monkey Blog
Coterra Energy Reports Strong Q2 Growth Despite Lowered Price Targets and Boosts Dividend Appeal
The company’s Q2 2025 earnings results were released on August 4, 2025, highlighting a revenue of $1.97 billion, which significantly surpassed the consensus estimate of $1.73...
Phillips 66 Expands Refining Capacity and Strengthens Dividend Outlook Following Q2 Beat
On July 25, 2025, Phillips 66 (NYSE:PSX) reported a strong Q2 2025, with Adjusted EPS of $2.38 and revenues of $33.5 billion, both beating the analyst consensus estimates.
Merck Gains FDA Approval for KEYTRUDA QLEX and Supports Dividend Appeal
Merck & Co., Inc. (NYSE:MRK) reported an Adjusted EPS of $2.13 for the second quarter of 2025.
Chevron Advances with Hess Acquisition and Divestiture Plans While Maintaining Dividend Appeal
On August 1, 2025, Chevron Corporation (NYSE:CVX) reported Q2 2025 earnings of $2.5 billion, a huge drop from the prior year’s Q2 revenue of $4.4 billion.
Pfizer Raises EPS Guidance and Expands Cost-Cutting Plan While Boosting Dividend Appeal
Pfizer Inc. (NYSE:PFE)’s second-quarter results were reported on August 5, 2025, where it highlighted a year-over-year increase in revenue of 10%, reaching $14.7 billion.
Entero Therapeutics, Inc. (ENTO) Names Jason D. Sawyer as New CEO Amid Strategic Shift
Entero Therapeutics, Inc.
Relmada Therapeutics, Inc. (RLMD) Advances Oncology and CNS Therapies with Promising Phase 2 Data
Relmada Therapeutics, Inc. (NASDAQ:RLMD) is a clinical-stage biotech company that develops innovative therapies for oncology and central nervous system disorders.
Tiziana Life Sciences Ltd (TLSA) Secures U.S. DoD Grant to Advance Intranasal Foralumab for Spinal Cord Injury
Tiziana Life Sciences Ltd (NASDAQ:TLSA) is a clinical-stage biotech company focused on next-generation immunomodulation therapies for neuroinflammatory and neurodegenerative diseases...
NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is a biopharmaceutical company specializing in anti-infective therapies for inflammation and infection-related conditions.
Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial
Lineage Cell Therapeutics, Inc.
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization
Precigen, Inc. (NASDAQ:PGEN) is a biotechnology company developing precision genetic medicines for oncology, infectious diseases, and rare conditions.
Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203
Matinas BioPharma Holdings, Inc.
Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials
Galectin Therapeutics Inc.
I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer
I-Mab (NASDAQ:IMAB) is a U.S.-based biotechnology company focused on precision immuno-oncology, developing differentiated therapies for cancer.
ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies
ABVC BioPharma, Inc. (NASDAQ:ABVC) tops our list for being one of the best penny stocks.
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) continues to advance its mission to transform patient lives through innovative therapies for conditions with limited treatment options.
Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up
Elanco Animal Health Incorporated (NYSE:ELAN), a global leader in veterinary pharmaceuticals and biologics, continues to advance its mission of improving animal health and food...
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth
Royalty Pharma plc (NASDAQ:RPRX), a leader in biopharma royalties, made major strategic moves in September 2025.
Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies
In September 2025, PFE and BioNTech reported positive Phase 3 data for the LP.8.1-adapted COMIRNATY 2025-2026 COVID-19 vaccine.
EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela
Zoetis Inc. (NYSE:ZTS) continues to strengthen its position as a global leader in animal health, with steady growth and expanding innovation.
Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment
Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical leader in oncology, immunology, cardiovascular disease, and fibrosis, is undergoing major strategic changes...
Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis
Johnson & Johnson (NYSE:JNJ), a global healthcare leader, continues to strengthen its pharmaceuticals and immunology portfolio while delivering strong stock performance in 2025...
Eli Lilly and Company (LLY) Unveils $5B Virginia Facility to Ramp Up Bioconjugate and Monoclonal Antibody Production
Eli Lilly and Company (NYSE:LLY) tops our list for being one of the best pharmaceutical stocks.
Analyst Says Nvidia ‘Getting Into’ Advanced Micro Devices (AMD) Business With Intel Deal
We recently published These 10 Stocks are Buzzing After Important Analyst Calls. Advanced Micro Devices, Inc.
14 Best FMCG Stocks to Invest In
Economic uncertainty has left businesses and consumers on edge as the U.S. continues to wage a ferocious tariff war. Nevertheless, U.S.
FUTR Accelerates US Growth with Charlie Obaugh Auto Group Deal
The FUTR Corporation (TSXV:FTRC) (OTCQB:FTRCF) is accelerating its US expansion with a brand-new enterprise deal: Charlie Obaugh Auto Group in Virginia will now offer customers...
Celsius (CELH) Extends Losses as Funds Flock to AI
Shares of Celsius Holdings dropped for a third consecutive day on Monday, shedding 6.19 percent to close at $51.34 apiece as investor funds fled to artificial intelligence stocks...
NIO (NIO) Falls 6% on Vehicle Delivery Delays
NIO saw its share prices decline by 6.24 percent on Monday as investor sentiment was dampened by news that strong demand for a newly launched vehicle has resulted in a six-month...
Zillow Group (Z) Extends Drop on Homebuyer Deception Claims
Shares of Zillow Group declined for a third straight day on Monday, slashing 6.57 percent to end at $81.04 apiece as investors sold off positions following a new lawsuit that ...
Magnite (MGNI) Ends 3-Day Run as Funds Flock to AI
Shares of Magnite snapped a three-day winning streak on Monday, shedding 6.79 percent to finish at $24.16 apiece as investor funds fled to artificial intelligence stocks amid ...
Kenvue (KVUE) Falls to New All-Time Low as Trump Hits Tylenol
In an extraordinary conference at the White House, Trump delivered advice to pregnant women and parents of young children, telling them not to take over-the-counter painkillers...
Bitmine Immersion (BMNR) Ends 4-Day Run After $365-Million Share Sale
Bitmine Immersion snapped a four-day winning streak on Monday, shedding 10.10 percent to finish at $55.10 apiece as investors disposed of shares following plans to raise $365....
Opendoor Technologies (OPEN) Falls Hard as Funds Turn to AI Stocks
Shares of Opendoor Technologies dropped for a third consecutive day on Monday, losing 12.43 percent to end at $8.38 apiece as investor funds shifted to higher-yielding assets ...
Quantum Computing (QUBT) Slashes 13% on $500-Million Share Sale
Quantum Computing snapped a four-day winning streak on Monday, losing 13.15 percent to end at $20.21 apiece after announcing a $500 million share sale that could result in the...
Compass Inc. (COMP) Nosedives 15.7% on $10-Billion All-Stock Merger With Anywhere Real Estate
Compass saw its share prices decline by 15.74 percent on Monday to end at $7.92 as investors unloaded positions after announcing plans to acquire Anywhere Real Estate for $10 ...
Cosan SA (CSAN) Bleeds Heavily on 2-Billion Share Sale
Cosan extended its losing streak to a third straight day on Monday, shedding 17.84 percent to end at $4.65 apiece as investor sentiment was dampened by plans to raise its capital...
Teradyne (ETR) Extends 4-Day Run as Analyst Goes Bullish on PT, Rating
Teradyne extended its winning streak for a fourth consecutive day on Monday, jumping 12.79 percent to close at $135.18 apiece as investors took heart from an analyst’s upgraded...
YPF Sociedad (YPF) Ends Losing Streak as US Pledges Lifeline to Ailing Argentina
YPF Sociedad Anónima (NYSE:YPF) snapped a three-day losing streak on Monday, climbing 12.78 percent to finish at $26.92 apiece, as investors cheered the US Treasury’s financial...
Fluence Energy (FLNC) Extends 3-Day Run as Firm Bags 133MW Deal in Poland
Fluence extended its winning streak to a third straight day on Monday, surging 13.25 percent to end at $10.60 apiece as investors welcomed the bagging of a new supply deal for...
First Majestic (AG) Jumps to New High as Silver Prices Hit New Record
During the session, First Majestic Silver Corp.
Hedge Fund Resource Center
